Calvet X, Navarro M, Gil M, Lafont A, Sanfeliu I, Brullet E, Campo R, Dalmau B, Rivero E, Mas P
Department of Internal Medicine, Consorci Hospitalari del Parc Taulí, Sabadell, Barcelona, Spain.
Am J Gastroenterol. 1998 Dec;93(12):2501-7. doi: 10.1111/j.1572-0241.1998.00711.x.
The aim of this study was to investigate the clinical and epidemiological factors associated with the appearance of peptic ulcer in patients with cirrhosis and, in particular, the role of Helicobacter pylori infection.
A total of 201 of 220 consecutive patients included in a prospective study that aimed to evaluate the effect of dietary intervention on cirrhotic complications and survival underwent upper gastrointestinal endoscopy. At entry, an epidemiological and clinical questionnaire was completed and the presence of peptic ulcer disease or esophageal varices at endoscopy was prospectively collected. Sera were obtained and stored at -70 degrees C until analyzed, being tested afterward for Helicobacter pylori antibodies using a commercial ELISA kit.
Eleven of 201 patients had borderline anti-Helicobacter pylori IgG titers and were excluded from further analysis. In the remaining 190 patients, point prevalence of peptic ulcer was 10.5% and lifetime prevalence 24.7%. Multivariate analysis selected male sex (OR 2.3; 95%CI 1.09-4.89) and Helicobacter pylori seropositivity (OR: 1.7, 95%CI 1.02-2.81) as the variables independently related to peptic ulcer disease.
Male sex and seropositivity for Helicobacter pylori are the major risk factors for peptic ulcer in cirrhosis.
本研究旨在调查肝硬化患者消化性溃疡出现的临床和流行病学因素,特别是幽门螺杆菌感染的作用。
一项旨在评估饮食干预对肝硬化并发症和生存影响的前瞻性研究纳入了220例连续患者,其中201例接受了上消化道内镜检查。入院时,完成了一份流行病学和临床问卷,并前瞻性收集了内镜检查时消化性溃疡疾病或食管静脉曲张的情况。采集血清并储存在-70℃直至分析,之后使用商用ELISA试剂盒检测幽门螺杆菌抗体。
201例患者中有11例幽门螺杆菌IgG滴度处于临界值,被排除在进一步分析之外。在其余190例患者中,消化性溃疡的点患病率为10.5%,终生患病率为24.7%。多变量分析选择男性(比值比2.3;95%置信区间1.09 - 4.89)和幽门螺杆菌血清阳性(比值比:1.7,95%置信区间1.02 - 2.81)作为与消化性溃疡疾病独立相关的变量。
男性和幽门螺杆菌血清阳性是肝硬化患者消化性溃疡的主要危险因素。